Search

everythinglearnresearchcommunity

for

Search:↓

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

A 23-year-old woman with Hashimoto’s thyroiditis improved significantly after a 15-month integrative treatment plan.

The article concludes that hormonal therapy is an effective long-term acne treatment, even for those without hormonal imbalances.

Trichoscopy is a useful non-invasive method for diagnosing different hair loss conditions.

COVID-19 infection may trigger alopecia areata in some patients.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Deep learning effectively diagnoses scalp disorders, but improvements are needed.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

NAFLD in PCOS patients is linked to early kidney problems.

More research is needed to understand alopecia areata severity.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.